3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Liver Metastases
1
Liver Malignancy
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Intraabdominal Infections
1
Head and Neck Neoplasms
1
Interventions
Paclitaxel
15
Carboplatin
9
liposomal doxorubicin
8
Bevacizumab
8
pembrolizumab
7
Topotecan
6
olaparib
4
mirvetuximab soravtansine
4
Nivolumab
4
Cyclophosphamide
4
niraparib
3
fludarabine
3
Gemcitabine
3
Drug Therapy
3
rucaparib
2
ribociclib
2
pegfilgrastim
2
palbociclib
2
oregovomab
2
fludarabine phosphate
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fulvestrant
2
Cisplatin
2
Blood Specimen Collection
2
1-dodecylpyridoxal
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
isoquercitrin
1
irinotecan sucrosofate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Positron Emission Tomography Computed Tomography
×
1 year
×
Clear all
No trials found.